Canopy Growth Corporation (NASDAQ:CGC – Get Free Report) Director Willy Kruh sold 10,451 shares of the stock in a transaction on Monday, September 29th. The stock was sold at an average price of $1.58, for a total value of $16,512.58. Following the completion of the transaction, the director directly owned 62,939 shares in the company, valued at $99,443.62. This trade represents a 14.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Canopy Growth Stock Performance
Shares of NASDAQ:CGC opened at $1.38 on Thursday. The firm has a market capitalization of $330.99 million, a PE ratio of -0.46 and a beta of 0.71. The company has a debt-to-equity ratio of 0.59, a current ratio of 3.07 and a quick ratio of 2.12. The business has a 50-day moving average of $1.35 and a two-hundred day moving average of $1.30. Canopy Growth Corporation has a 12 month low of $0.77 and a 12 month high of $5.80.
Canopy Growth (NASDAQ:CGC – Get Free Report) last issued its earnings results on Friday, August 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. Canopy Growth had a negative return on equity of 89.93% and a negative net margin of 155.76%.The business had revenue of $52.98 million during the quarter, compared to analysts’ expectations of $64.98 million. As a group, research analysts forecast that Canopy Growth Corporation will post -2.81 earnings per share for the current year.
Hedge Funds Weigh In On Canopy Growth
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of Canopy Growth to a “hold” rating in a research note on Tuesday, August 12th. One research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Sell”.
View Our Latest Analysis on Canopy Growth
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Featured Articles
- Five stocks we like better than Canopy Growth
- Are Penny Stocks a Good Fit for Your Portfolio?
- Datavault AI: The New AI Contender Backed by Big Funding
- Russell 2000 Index, How Investors Use it For Profitable Trading
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- What is a Special Dividend?
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.